Compound Detail
CHEMBL2058833
GANAPLACIDE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL2058833 |
| Name | GANAPLACIDE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | BUPRVECGWBHCQV-UHFFFAOYSA-N |
5
Targets
23
Activities
3
Assay Types
30
PK Parameters
20
Publications
7
Known Names
2
Indications
Molecular Properties
411.5
MW (Da)
3.61
ALogP
5
HBA
2
HBD
76.2
PSA (Ų)
0.69
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Malaria Malaria, Falciparum
Activity Summary
IC50 12 meas. best 8.06
EC50 10 meas. best 8.26
Ki 1 meas. best 6.81
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Plasmodium vivax CHEMBL613013 | EC50 | 8.26 | 8.26 | 5.5 | 1 |
| Plasmodium falciparum CHEMBL364 | EC50 | 8.22 | 7.5278 | 6.0 | 9 |
| Unchecked CHEMBL612545 | IC50 | 8.06 | 7.5044 | 8.8 | 9 |
| Plasmodium falciparum CHEMBL364 | IC50 | 7.8 | 7.8 | 16.0 | 1 |
| Cytochrome P450 3A4 CHEMBL340 | Ki | 6.81 | 6.81 | 156.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 4.87 | 4.87 | 13400.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 5003.35 | ng.hr.mL-1 | Mus musculus |
| AUC | 1694.8 | ng.hr.mL-1 | Mus musculus |
| AUC | 200.38 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 753.38 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 400.76 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 3018.88 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 14351.72 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 83000000.0 | ng.hr.mL-1 | Homo sapiens |
| CL | 49.2 | mL.min-1.kg-1 | Mus musculus |
| CL | 67.5 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 90.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 37.8 | mL.min-1.kg-1 | Mus musculus |
| CL | 548.0 | mL.min-1.kg-1 | Mus musculus |
| Cmax | 1538.0 | nM | Mus musculus |
| Cmax | 126.0 | nM | Rattus norvegicus |
| Cmax | 91.0 | nM | Rattus norvegicus |
| Cmax | 580.0 | nM | Rattus norvegicus |
| Cmax | 34885.0 | nM | Rattus norvegicus |
| Cmax | 337.82 | nM | Rattus norvegicus |
| Cmax | 18.47 | nM | Homo sapiens |
| F | 74.0 | % | Mus musculus |
| F | 20.0 | % | Rattus norvegicus |
| F | 40.0 | % | Rattus norvegicus |
| F | 57.0 | % | Rattus norvegicus |
| F | 48.0 | % | Rattus norvegicus |
| F | 74.0 | % | Mus musculus |
| T1/2 | 4.35 | hr | Mus musculus |
| T1/2 | 2.0 | hr | Mus musculus |
| T1/2 | 4.6 | hr | Rattus norvegicus |
| T1/2 | 4.7 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine